China’s promising pancreatic cancer treatment to start clinical trials after showing ‘superior efficacy’
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Innovative drug performs well against current frontline treatments, wins approval to proceed towards human testing.